Telematics in Heavy Equipment Market worth US$1,743.8 Million by 2025 - TMR
Feb 26, 2018 12:29 pm UTC| Business
ALBANY, New York, Feb. 26, 2018 -- The vendor landscape of the global telematics in heavy equipment market is becoming increasingly competitive due to the rising number of companies and the rapid pace of...
Feb 26, 2018 12:19 pm UTC| Business
ALBANY, New York, Feb. 26, 2018 -- According to the report, the global agricultural drone market will expand at an exponential 21.35 CAGR from 2018 to 2026, rising to a valuation of US$1,932.6 mn by 2026. The vendor...
Artios Pharma Appoints Pierre Legault as Chairman of its Board of Directors
Feb 26, 2018 12:16 pm UTC| Business
Artios Pharma Ltd. ("Artios" or "the Company") Artios Pharma Appoints Pierre Legault as Chairman of its Board of Directors Industry leader who brings over 35 years of experience in developing successful...
The Joint Corp. to Present at the 30th Annual ROTH Conference
Feb 26, 2018 12:05 pm UTC| Business
SCOTTSDALE, Ariz., Feb. 26, 2018 -- The Joint Corp. (NASDAQ:JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it will present at the 30th Annual ROTH Conference on Tuesday, March 13th...
Global Semiconductor Automated Test Equipment (ATE) Business Market Report 2018
Feb 26, 2018 12:04 pm UTC| Business
Dublin, Feb. 26, 2018 -- The "Semiconductor Automated Test Equipment (ATE) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The report provides separate...
ObsEva SA Reports Positive Topline Results from IMPLANT2 Phase 3 Clinical Trial of Nolasiban in IVF
Feb 26, 2018 12:01 pm UTC| Business
The WHO considers infertility a global public health issue affecting 186 million people, and only 1 in 4 ART treatments results in childbirth Geneva, Switzerland and Boston, MA - 26 February, 2018 - ObsEva SA...
Feb 26, 2018 12:01 pm UTC| Business
CARMIEL, Israel, Feb. 26, 2018 -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed...